2025313
Other Heartseed has started CEO column, "TOP MESSAGE", on Investor Relation section of its website.
202523
PR Heartseed Announces Enrollment Completion in Phase 1/2 Clinical Trial using HS-001, an Investigational Stem Cell-Derived Therapy for Advanced Heart Failure
